Many CFOs who could benefit from the R&D tax credit choose not to claim it at all, not because their companies fail to qualify, but because of information gaps, risk perceptions, and how the credit gets positioned inside the organization. For some finance leaders, the path of least resistance is simply never filing.
We understand the instinct. When a decision touches the IRS, the option that feels safest is often the one you don’t make. But after more than 23 years and over 65,000 completed studies, we’ve watched that instinct cost companies money they had already earned through the technical work they were doing anyway. Our role at CSSI is to close the gap between what CFOs assume the R&D credit requires and what it actually requires, so the decision to pursue it is based on a clear picture rather than an educated guess.
Here’s how we think about the concerns CFOs raise most often, and how we work through them directly.
“It only pencils out for companies that can afford Big Four rates.”
Cost is a legitimate concern, especially for small and midsize firms that assume the credit is scaled for enterprise budgets. It’s also the reason many qualified companies never look into it at all.
CSSI addresses this at the front end with a no-cost analysis. Before any commitment, we review a company’s actual technical work and estimate what may qualify and what the potential benefit could look like. That means the decision to move forward is made with real numbers in hand, not a hypothetical. It also means a CFO can weigh the cost of pursuing a study against a defensible estimate of the benefit, rather than against an assumption borrowed from how larger firms are billed.
Frequent changes to how R&D expenses are treated under federal tax law make long-range capital planning harder, and that concern is fair too. This is one of the reasons we treat a CSSI study as an ongoing conversation with a CFO and their CPA rather than a one-time transaction. As the law shifts, the impact on a specific company’s credit position should be revisited, not assumed to be static.
“The documentation burden and audit exposure aren’t worth it.”
This is often the concern with the most weight behind it, and for good reason. IRS filing requirements around business components have gotten more demanding, and a few high-profile Tax Court decisions have understandably made finance teams more cautious about audit risk.
Our answer to this isn’t to downplay the risk. It’s to remove the guesswork around it. CSSI’s studies are built on the same engineering-based methodology across every service we offer: qualifying activity is tied to the IRS’s four-part test, technical uncertainty and the process of experimentation are documented as they happen rather than reconstructed after the fact, and every dollar in a credit calculation is traced back to a specific, supportable activity. A study built this way isn’t a year-end, check-the-box exercise. It’s designed to hold up if it’s ever examined, and CSSI stands behind that work if a study we prepared is audited.
Being conservative and precise here matters more to us than maximizing a number. A credit that can’t be defended isn’t a benefit; it’s a liability with a delay on it. Our approach is built around audit safety and defensibility first, because that’s what actually protects the value a company has earned.
“This is a lab-coat, big-tech incentive. It’s not built for us.”
This may be the most persistent misconception, and it’s one we hear across nearly every industry we work with. Engineering firms, manufacturers, food and beverage companies, software teams, and oil and gas operators regularly perform work that meets the technical bar for the credit, often without anyone in the organization thinking of it as “R&D.” Developing a new production process, reformulating a product to meet a new requirement, or solving an architecture problem that doesn’t have an obvious answer can all qualify, whether or not the company has a department with “research” in its name.
The other side of this perception is treating the credit as year-end cleanup rather than a cash-flow lever. When it’s positioned that way, it competes for attention with year-end closing tasks and tends to lose. When it’s positioned as part of capital allocation planning, reviewed annually alongside other financial decisions, it becomes a resource a CFO can actually plan around.
Bridging the gap: transparency, discussion, and planning
The column’s underlying argument is one we agree with: perception, more than fact, is what keeps qualified companies from claiming a credit they’ve earned. Closing that gap is the actual work.
For CSSI, that means three things in practice. First, transparency before commitment: a no-cost analysis that shows what a company’s specific activities may be worth, so the decision is grounded in an estimate rather than an assumption. Second, open discussion throughout the process: we work directly with the CFO and their tax advisor, walking through what qualifies, what doesn’t, and why, rather than delivering a number without the reasoning behind it. Third, treating the credit as part of ongoing planning rather than a once-a-year decision, so that as tax law and the business evolve, the CFO’s understanding of the opportunity evolves with it.
Risk perception and actual risk aren’t always the same thing, but the only way to know the difference is to look closely enough to tell them apart. That’s the conversation we’re built to have.
Curious what your own R&D activity might be worth, without committing to anything? Request a free analysis from CSSI, and let’s look at the facts together.
FAQs About the R&D Tax Credit and CFO Concerns
Why do some CFOs avoid claiming the R&D tax credit even when their company may qualify?
Most often it comes down to information gaps rather than ineligibility. CFOs may assume the credit is cost-prohibitive, worry about IRS scrutiny, or believe the credit only applies to labs and big tech. A no-cost analysis is designed to replace those assumptions with an actual picture of what a company’s work could be worth.
What does a no-cost R&D tax credit analysis involve?
CSSI reviews a company’s actual technical work, without charge and without commitment, to estimate what activities may qualify and what the potential benefit could look like. That estimate gives a CFO real numbers to weigh before deciding whether to move forward with a full study.
Is the R&D tax credit only available to large technology companies?
No. Engineering firms, manufacturers, food and beverage companies, software teams, and oil and gas operators regularly perform work that meets the IRS’s four-part test. Qualification depends on the nature of the technical work, not the size of the company or the name of the department doing it.
How does CSSI address audit risk for R&D tax credit studies?
Every CSSI study ties qualifying activity to the IRS’s four-part test and documents the technical uncertainty and experimentation behind it as the work happens, rather than reconstructing it later. Studies are built to hold up under examination, and CSSI stands behind the work if a study we prepared is audited.
Does claiming the R&D tax credit require a dedicated research department?
No. Many companies perform qualifying work through product development, engineering, or quality teams without labeling it “R&D.” What matters is whether the activity involved genuine technical uncertainty and a process of experimentation, not the name of the team doing it.
How often should a company revisit its R&D tax credit position?
Because tax law affecting R&D expense treatment changes periodically, CSSI treats a study as an ongoing conversation rather than a one-time transaction, revisiting a company’s credit position with its CFO and CPA as the law and the business evolve.
